NCT04327479View on ClinicalTrials.gov

Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection

CompletedOBSERVATIONAL
Enrollment

728

Participants

Timeline

Start Date

March 26, 2020

Primary Completion Date

March 25, 2022

Study Completion Date

July 25, 2022

Conditions
Cardiovascular DiseasesCardiovascular Risk FactorSARS
Interventions
DIAGNOSTIC_TEST

Assessment of cardiovascular diseases and cardiovascular risk factors

At inclusion, patients will be screened for pre-existing cardiovascular diseases and cardiovascular risk factors, as well as medication.

Trial Locations (1)

45147

University Hospital Essen, Essen

All Listed Sponsors
lead

University Hospital, Essen

OTHER

NCT04327479 - Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection | Biotech Hunter | Biotech Hunter